Mance E. Buttram

Affiliation confirmed via AI analysis of OpenAlex, ORCID, and web sources.

Federal Grant PI

Associate Professor

University of Arkansas

Also affiliated: Florida Department of Health (2015); OSRAM (United States) (2015–2016); Florida International University (2014); Nova Southeastern University (2012–2020); Zoo Miami (2015); Human Growth Foundation (2024); Arkansas Department of Health (2022)

Faculty Researcher

19 h-index 129 pubs 1,261 cited

Research Areas

Biomedical Subjects

Links

ORCID Research Group

OverviewAI-generated summary

Mance E. Buttram's research focuses on substance use disorders, particularly opioid use disorder, and its co-occurring issues, including HIV infections and sexually transmitted infections. Buttram currently serves as PI on a $137,885 NIH/National Institute on Drug Abuse grant examining the concomitant non-medical use of gabapentin and opioids.

Recent publications investigate the associations between transactional sex and sexually transmitted infections among individuals with opioid use disorder, the impact of socio-environmental factors on doxycycline post-exposure prophylaxis awareness, and the nonmedical use of gabapentin and opioid agonist medications. Other work examines kratom-related state policy environments and kratom use, gabapentin use among individuals initiating buprenorphine treatment, increasing rates of buprenorphine diversion, and motivations for gabapentin use with opioid agonist medications. Buttram has also studied geographic and racial/ethnic differences in access to methamphetamine detoxification services.

Buttram's scholarship metrics include an h-index of 19, 129 total publications, and 1,214 total citations. Buttram leads a research group at the University of Arkansas at Fayetteville and collaborates with researchers including Krishen D. Samuel, Yamilka Stivers, Corinne L. Chandler, and Kayla E. Simon.

Metrics

h-index: 19
Publications: 129
Citations: 1,261

Selected Publications

HIV Pre-Exposure Prophylaxis Awareness among Individuals in Treatment for Opioid Use Disorder in the United States: A Cross-Sectional Study (2026)

AIDS and Behavior DOI OpenAlex
Gabapentin-Related State Policies and Associations with Gabapentin Non-Medical Use Among a Nationally Representative Population in the United States (2025)

Substance Use & Misuse 2 citations DOI OpenAlex
Pharmaceutical stimulant diversion, 2002–2022: data from a national sample of law enforcement and regulatory agencies in the US (2025)

Drugs Education Prevention and Policy DOI OpenAlex
It’s Like Disney … You Have to Find Them a Fantasy: Latino Sexual Minority Men at the Intersection of Tourism, Sex, Drug Use, and HIV in Miami-South Beach (2025)

The Journal of Sex Research DOI OpenAlex
Recreational Ketamine Use among Individuals with Opioid Use Disorder: Demographics, Motivations, and Polysubstance Use (2025)

Substance Use & Misuse 1 citation DOI OpenAlex
Pharmaceutical Stimulant Diversion, 2002-2022: Data from a National Sample of Law Enforcement and Regulatory Agencies (2025)

Drug and Alcohol Dependence DOI OpenAlex
The Informal, Non-Prescribed Use of Antiretroviral Medications for PrEP Among a National US-Based Sample of Gay, Bisexual, and Other Men Who Have Sex with Men: A Cross-Sectional Study (2024)

AIDS and Behavior 2 citations DOI OpenAlex
Understanding Ketamine Use in Treatment-Seeking Persons With Opioid Use Disorder (2024)

Drug and Alcohol Dependence DOI OpenAlex
GABAPENTIN UTILIZATION AMONG BUPRENORPHINE-PRESCRIBED INDIVIDUALS WITH OPIOID USE DISORDER AND ASSOCIATED RISK OF OVERDOSE (2024)

Drug and Alcohol Dependence DOI OpenAlex
Associations Between Kratom-Related State Policy Environments and Kratom Use in a Nationally Representative Population in the United States (2024)

Drug and Alcohol Dependence DOI OpenAlex
Geographic and Racial/Ethnic Differences in Access to Methamphetamine Detoxification Services, United States, 2021 (2024)

Medical Care 4 citations DOI OpenAlex
The impact of socio-environmental factors on doxycycline post-exposure prophylaxis awareness in the US: a cross-sectional study (2024)

Sexual Health 12 citations DOI OpenAlex
Stigma Related to the Non-Medical Use and Diversion of Prescription Stimulant Drugs: Should We Care (2024)

Substance Use & Misuse 2 citations DOI OpenAlex
Gabapentin Use Among Individuals Initiating Buprenorphine Treatment for Opioid Use Disorder (2023)

JAMA Psychiatry 13 citations DOI OpenAlex
Law enforcement experiences with gabapentin: non-medical use, diversion, and state controlled substances laws (2023)

Journal of Substance Use 2 citations DOI OpenAlex